2026 David H. Munn: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	105	580	536	345	314	299	48319
Medicine	105	6704	6302	3539	3283	300	48384

Overview

David H. Munn is affiliated with Augusta University in the United States. Their research primarily spans the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these domains, their work is further specialized in Immunology, Oncology, Molecular Biology, Genetics, and Neurology.

The scientist has contributed extensively to topics related to immune cell function and interaction, cancer immunotherapy and biomarkers, immunotherapy and immune responses, immune cells in cancer, glioma diagnosis and treatment, CAR-T cell therapy research, and adenosine and purinergic signaling.

Frequent publication venues for their research include Neuro-Oncology, the Journal for ImmunoTherapy of Cancer, The Journal of Immunology, Cancer Cell, and Blood.

Their recent papers include the following:

The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling, 2020, Immunity
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint, 2020, Nature Communications
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses, 2022, Cancer Cell
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma, 2020, Clinical Cancer Research
Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment, 2023, Cancer Cell

Among the frequent co-authors collaborating with David H. Munn are Rafał Pacholczyk, Ramses Sadek, Theodore S. Johnson, Eugene P. Kennedy, and Zuzana Berrong.

Best Publications

Prevention of allogeneic fetal rejection by tryptophan catabolism

David H. Munn;Min Zhou;John T. Attwood;Igor Bondarev

3145
Citations
IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Andrew L. Mellor;David H. Munn

2928
Citations
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis

Nagendra Singh;Ashish Gurav;Sathish Sivaprakasam;Evan Brady

2345
Citations
INHIBITION OF T CELL PROLIFERATION BY MACROPHAGE TRYPTOPHAN CATABOLISM

David H. Munn;Ebrahim Shafizadeh;John T. Attwood;Igor Bondarev

1941
Citations
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

David H. Munn;Madhav D. Sharma;Babak Baban;Heather P. Harding

1449
Citations
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

David H. Munn;Madhav D. Sharma;Jeffrey R. Lee;Kanchan G. Jhaver

1331
Citations
Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

David H. Munn;Andrew L. Mellor

1284
Citations
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

David H. Munn;Madhav D. Sharma;Deyan Hou;Babak Baban

1094
Citations
Indoleamine 2,3 dioxygenase and metabolic control of immune responses

David H. Munn;Andrew L. Mellor

1043
Citations
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

David H. Munn;Andrew L. Mellor

1026
Citations
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou

978
Citations
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

Andrew L Mellor;David H Munn

830
Citations
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

Qing Zhou;Meghan E. Munger;Rachelle G. Veenstra;Brenda J. Weigel

792
Citations
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

Rikke B. Holmgaard;Dmitriy Zamarin;David H. Munn;Jedd D. Wolchok;Jedd D. Wolchok;Jedd D. Wolchok

712
Citations
Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses

De Yan Hou;Alexander J. Muller;Madhav D. Sharma;James DuHadaway

711
Citations
Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells

David H. Munn;Madhav D. Sharma;Andrew L. Mellor

622
Citations
Immune suppressive mechanisms in the tumor microenvironment.

David H Munn;Vincenzo Bronte

616
Citations
The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation

Wei Chen;Xueqing Liang;Amanda J. Peterson;David H. Munn

608
Citations
Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion

Andrew L. Mellor;Babak Baban;Phillip Chandler;Brendan Marshall

564
Citations
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells

Babak Baban;Phillip R. Chandler;Madhav D. Sharma;Jeanene Pihkala

552
Citations
Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Andrew L. Mellor;Jayabalan Sivakumar;Phillip Chandler;Kimberly Smith

545
Citations

Frequent Co-Authors

Andrew L. Mellor Newcastle University

Bruce R. Blazar University of Minnesota

Angela Panoskaltsis-Mortari University of Minnesota

Jonathan S. Serody University of North Carolina at Chapel Hill

William J. Murphy Texas A&M University

Huidong Shi Augusta University

Patricia A. Taylor University of Minnesota

Ivan Maillard University of Pennsylvania

George C. Prendergast Lankenau Institute for Medical Research

Geoffrey R. Hill Fred Hutchinson Cancer Research Center

External Links

Personal website of David H. Munn

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can offer diverse career opportunities. Accelerated nursing programs provide a fast-track path into nursing, making them ideal for individuals who want to quickly build clinical skills while supporting patient care related to immune health. You can find options that balance speed with quality through accelerated nursing programs.

Similarly, entering the workforce as a Licensed Practical Nurse (LPN) can be an efficient starting point. Many lpn programs easy to get into offer flexible schedules and foundational training, which complement further specialization in immunologic or infectious diseases.

Nurses aiming to expand their scope of practice might choose to pursue advanced degrees such as nurse practitioner programs. The easiest online nurse practitioner programs enable working professionals to study while maintaining their career, focusing on holistic patient care including immune system-related conditions.

For those passionate about mental health and immunology’s role in psychiatric conditions, programs like the best pmhnp programs offer specialized training with excellent clinical placements, preparing graduates to impact patient outcomes in this growing field.